Product Information

CLEMSZA 2.68 MG TABLET is a generic product labeled by IPG Pharmaceuticals, Inc., priced at $3.2635 per EA under NDC 71085008130. Its NADAC has been published 44 times since Jan 21, 2026.

FDA first approved this application on Jan 31, 1992.

CLEMSZA 2.68 MG TABLET

Clemastine Fumarate
$3.2635per EA

Strength

2.68 mg/1

NDC

71085008130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CLEMASTINE FUMARATE

Approval Type

Generic (ANDA)

FDA Application

ANDA073283

FDA Approved

1/31/1992

On Market Since

8/1/2025

Price Statistics

The NADAC for CLEMSZA 2.68 MG TABLET has been published 44 times since Jan 21, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$3.2635 per EA
All-time high$3.3560 (Apr 15, 2026)
All-time low$3.1775 (Sep 23, 2026)
52-week high$3.3560
52-week low$3.1775
Median price$3.3066
Average price$3.2883
Largest weekly change-3.1% (Aug 19, 2026)
Weeks tracked44
Tracking sinceJan 21, 2026

Price History

1W

+2.7%

1M

+2.7%

3M

+1.9%

6M

-2.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLEMSZA 2.68 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CLEMSZA 2.68 MG TABLET, manufactured by IPG Pharmaceuticals, Inc., is $3.2635 per EA (NDC 71085008130), effective Nov 18, 2026.

How has the price of CLEMSZA 2.68 MG TABLET changed over time?

Over the history we have for it, the NADAC for CLEMSZA 2.68 MG TABLET has held within roughly two percent of its current level. It has been tracked across 44 weekly CMS publications since Jan 21, 2026.

What are the highest and lowest recorded NADAC prices for CLEMSZA 2.68 MG TABLET?

Since Jan 21, 2026, the NADAC for CLEMSZA 2.68 MG TABLET has ranged from a low of $3.1775 (Sep 23, 2026) to a high of $3.3560 (Apr 15, 2026), with a median of $3.3066 per EA.

Are there cheaper alternatives to CLEMSZA 2.68 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLEMSZA 2.68 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CLEMSZA 2.68 MG TABLET?

CLEMSZA 2.68 MG TABLET (NDC 71085008130) is labeled by IPG Pharmaceuticals, Inc., and CMS classifies it as a generic product.